Traditional valuation approaches rarely take into account scientific considerations specific to a R&D project. A question-based approach using real options offers a solution.
Access options
Subscribe to Journal
Get full journal access for 1 year
66,34 €
only 5,53 € per issue
All prices include VAT for Germany.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.

References
- 1.
Bogdan, B. & Villiger, R. Valuation in Life Sciences, A Practical Guide (Springer-Verlag, 2007)
- 2.
Stewart, J. J., Allison, P. N. & Johnson, R. S. Nat. Biotechnol. 19, 813–817 (2001).
- 3.
Kola, I. & Landis, J. Nat. Rev. Drug Discov. 3, 711–715 (2004).
- 4.
Johal, S. S., Oliver, P. & Williams, H. C. J. Med. Mark. 8, 101–112 (2008).
- 5.
Pietzsch, J. B., Shluzas, L. A., Paté-Cornell, M. E., Yock, P. G. & Linehan, J. H. J. Med. Dev. 3, 021004-1–021004-15 (2009).
- 6.
ICH Expert Working Group. ICH Harmonised Tripartite Guideline: General Considerations for Clinical Trials E8, Step 4 version (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1997).
- 7.
Huchzermeier, A. & Loch, C. H. Manag. Sci. 47, 85–101 (2001).
- 8.
Harrison, M. H. & Lerer, L. Nat. Biotechnol. 29, 223 (2002).
- 9.
Stewart, J. J. Nat. Biotechnol. 29, 223–224 (2002).
- 10.
Villiger, R. & Bogdan, B. Drug Discov. Today 9, 552–553 (2004).
- 11.
Nichols, N. Harv. Bus. Rev. 72, 89–99 (1994).
- 12.
Hartmann, M. & Ali Hassan, A. Res. Policy 35, 343–354 (2006).
- 13.
Evers, R. et al. Clin. Pharmacol. Ther. 96, 291–295 (2014).
- 14.
Dolgos, H. et al. Drug Discov. Today 21, 517–526 (2016).
- 15.
Kenter, M. J. H. & Cohen, A. F. Lancet 368, 1387–1391 (2006).
- 16.
de Visser, S. A Question Based Approach to Drug Development. PhD Thesis, Leiden Univ. (Leiden, the Netherlands, 2003).
- 17.
Cohen, A. F., Burggraaf, J., van Gerven, J. M. A., Moerland, M. & Groeneveld, G. J. Annu. Rev. Pharmacol. Toxicol. 55, 55–74 (2015).
- 18.
Zhang, S. & Babovic, A. Decis. Support Syst. 51, 119–129 (2011).
Author information
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Supplementary Materials
Supplementary Figs. 1 and 2 and Supplementary Table 1
Rights and permissions
About this article
Cite this article
de Visser, S.J., Cohen, A.F. & Kenter, M.J.H. Integrating scientific considerations into R&D project valuation. Nat Biotechnol 38, 14–18 (2020). https://doi.org/10.1038/s41587-019-0358-x
Published:
Issue Date: